INTECH Investment Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$134K Sell
10,264
-3,178
-24% -$36.2K ﹤0.01% 1888
2026
Q1
$153K Sell
13,442
-4,073
-23% -$44.1K ﹤0.01% 1813
2025
Q4
$225K Hold
17,515
– – ﹤0.01% 1922
2025
Q3
$196K Sell
17,515
-2,027
-10% -$19.6K ﹤0.01% 2077
2025
Q2
$194K Sell
19,542
-1,127
-5% -$11K ﹤0.01% 2102
2025
Q1
$194K Buy
20,669
+4,129
+25% +$43.4K ﹤0.01% 2103
2024
Q4
$152K Buy
+16,540
New +$122K ﹤0.01% 2113

Other funds holding ANGO

INTECH Investment Management's ANGO Position: Q2 2026 in Review

INTECH Investment Management reduced its AngioDynamics (ANGO) stake by 24% in Q2 2026, selling an estimated $36.2K and leaving 10,264 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #1888.

INTECH Investment Management first reported a position in ANGO in Q4 2024 and has held it in 7 quarters since. The position peaked at $225K in Q4 2025. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • INTECH Investment Management held 10,264 shares of AngioDynamics worth $134K as of Q2 2026.
  • INTECH Investment Management sold 3,178 AngioDynamics shares in Q2 2026, an estimated $36.2K.
  • AngioDynamics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1888 holding.
  • INTECH Investment Management first reported a position in AngioDynamics in Q4 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's AngioDynamics position peaked at $225K in Q4 2025.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.